LT - Riluzolo, rilizolo provaistų arba riluzolo analogų panaudojimas kartu su imunoterapijomis vėžio formų gydymui
EN - USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/428 |
(2006.01) |
|
|
C07D 277/82 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
3458053 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
17800310.9 |
|
Date of filing the European patent application |
2017-05-19 |
| (97) |
Date of publication of the European application |
2019-03-27 |
| (45) |
Date of publication and mention of the grant of the patent |
2021-12-08
|
| (46) |
Date of publication of the claims translation |
2022-02-25
|
PCT application
| (86) |
Number |
PCT/US2017/033688 |
|
Date |
2017-05-19 |
PCT application publication
| (87) |
Number |
WO 2017/201501 |
|
Date |
2017-11-23 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201662339433 P |
2016-05-20
|
US |
Inventors
| (72) |
CORIC, Vladimir , US
|
Grantee
| (73) |
Biohaven Pharmaceutical Holding Company Ltd. ,
234 Church Street
Suite 301, New Haven, CT 06520,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
Riluzolo, rilizolo provaistų arba riluzolo analogų panaudojimas kartu su imunoterapijomis vėžio formų gydymui |
| |
USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-04-22 |
9 |
208.00
EUR
|
Next renewal fee
|
2026-05-19 |
